Skip to content
Back to recalls
Drug FDA Class III Ongoing Mislabeling

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

STAQ Pharma, Inc. Published Oct 22, 2025

Risk level

Class III

Unlikely to cause harm, but violates labeling or manufacturing rules.

Severity score 40/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact STAQ Pharma, Inc. or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Affected products (1)

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Code info: Lot #: 25104595A, Expiry: 27DEC2025.

Affected areas

Nationwide

Timeline

  1. Initiated
    Oct 9, 2025
  2. Published
    Oct 22, 2025
Recall number
D-0023-2026
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.